R&D LSX 2024 - James Graham, Recce Pharma A lot of ink has been spilled about the anti-microbial resistance space and why it’s so hard to create a profitable company in it.
Oncology ESMO 2024 – Magda Meissner In our penultimate video from ESMO 2024, pharmaphorum spoke with Dr Magda Meissner, consultant medical oncologist at the Velindre Cancer Centre and project lead for QuicDNA, about how a sim
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.
